Virology

Papers
(The H4-Index of Virology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Growth, detection, quantification, and inactivation of SARS-CoV-2213
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies183
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells115
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway82
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution78
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity71
Association of viral load with serum biomakers among COVID-19 cases64
Antiviral activity of lycorine against Zika virus in vivo and in vitro58
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series51
Programmed −1 Ribosomal Frameshifting in coronaviruses: A therapeutic target51
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability43
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution41
H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021–April 202241
Glial cell response to Epstein-Barr Virus infection: A plausible contribution to virus-associated inflammatory reactions in the brain38
On the road to ending the COVID-19 pandemic: Are we there yet?36
A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE235
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-234
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses34
The pharmacology of plant virus nanoparticles31
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques31
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)30
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE229
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein29
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan29
Insect-Specific Viruses: An overview and their relationship to arboviruses of concern to humans and animals29
CRISPR-Cas12a combined with reverse transcription recombinase polymerase amplification for sensitive and specific detection of human norovirus genotype GII.428
New insights into the evolutionary features of viral overlapping genes by discriminant analysis28
Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody28
Virome characterization of Cryphonectria parasitica isolates from Azerbaijan unveiled a new mymonavirus and a putative new RNA virus unrelated to described viral sequences28
Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.28
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E28
0.029641151428223